IP Library Granted Patent US 6,936,448
Granted Patent B2
US 6,936,448 · App. 10/040,863 · Granted Aug 30, 2005

Nucleic acids and proteins of a rat ganglioside GM1-specific α1-2fucosyltransferase and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,936,448
App. No.
10/040,863
Granted
Aug 30, 2005
Kind
B2
Abstract

A rat ganglioside GM 1 -specific α1→2fucosyltransferase is disclosed. Nucleotide sequences of a rat ganglioside GM 1 -specific α1→2fucosyltransferase, amino acid sequences of its encoded protein (including peptide or polypeptide), and derivatives thereof are described. Also described are fragments (and derivatives and analogs thereof) which comprise a domain of rat ganglioside GM 1 -specific α1→2fucosyltransferase with catalytic activity. Methods of production of rat ganglioside GM 1 -specific α1→2fucosyltransferase and derivatives and analogs thereof (e.g. by recombinant means) are provided. Methods of inhibiting the function of rat ganglioside GM 1 -specific α1→2fucosyltransferase (e.g. by means of antisense RNA) are provided. Methods of commercial scale use of the rat ganglioside GM 1 -specific α1→2fucosyltransferase in the production of fucosyl-saccharide compositions are described. Applications of these compositions, e.g. as additives for human nutritive compositions or immunotherapeutics for cancer, are disclosed.

Claims (29)

1. A method for the preparative synthesis of a molecule comprising Fucα1→2Galβ1→3GalNAc, said method comprising contacting, a recombinant α1→2 fucosyltransferase comprising an amino acid sequence as depicted in FIG. 5 (SEQ ID NO: 8) with GDP-fucose and a molecule having a terminal Galβ1→3GalNAc moiety and recovering a molecule comprising Fucα1→2Galβ1→3GalNAc.

2. A method for the preparative synthesis of a glycolipid, glycoprotein, glycolipoprotein or free oligosaccharide comprising Fucα1→2Galβ1→3GalNAc, said method comprising contacting, a recombinant protein comprising an amino acid sequence as depicted in FIG. 5 (SEQ ID NO: 8) with GDP-fucose and a glycolipid, glycoprotein, glycolipoprotein or free oligosaccharaide having a terminal Galβ1→3GalNAc moiety and recovering the glycolipid, glycoprotein, glycolipoprotein or free oligosaccharaide comprising Fucα1→2Galβ1→3GalNAc.

3. The method according to claim 2 wherein the α1→2 fucosyltransferase is contacted with an oligosaccharaide comprising a terminal Galβ1→3GalNAc moiety.

4. A method for the preparative synthesis of fucosyl-GM1 comprising contacting, a recombinant α1→2 fucosyltransferase comprising an amino acid sequence as depicted in FIG. 5 (SEQ ID NO: 8) with GDP-fucose and the ganglioside GM1 and recovering fucosyl-GM1.

5. A method for the preparative synthesis of a molecule comprising Fucα1→2Galβ1→3GalNAc, said method comprising contacting,

(a) a recombinant α1→2 fucosyltransferase comprising the amino acid sequence depicted in FIG. 5 (SEQ ID NO: 8), or

(b) a cellular fraction of a recombinant cell containing a vector having a nucleotide sequence that encodes and expresses the recombinant α1→2 fucosyltransferase of (a), said cellular fraction containing the recombinant α1→2 fucosyltransferase and having α1→2 fucosyltransferase activity,

with GDP-fucose and a molecule having a terminal Galβ1→3GalNAc moiety and recovering a molecule comprising Fucα1→2Galβ1→3GalNAc.

6. A method for the preparative synthesis of a glycolipid, glycoprotein, glycolipoprotein or free oligosaccharaide comprising Fucα1→2Galβ1→3GalNAc, said method comprising contacting,

(a) a recombinant rat α1→2fucosyltransferase of encoded by the nucleotide sequence depicted as SEQ ID NO: 7, or

(b) a cellular fraction of a recombinant cell containing a vector having and expresing the nucleotide sequence as depicted as SEQ ID NO: 7, said cellular fraction containing the recombinant rat α1→2fucosyltransferase of (a) and having α1→2 fucosyltransferase activity,

with GDP-fucose and a glycolipid, glycoprptein, glycolipoprotein or oligosaccharide having a terminal Galβ1→3GalNAc moiety and recovering a glycolipid, glycoprotein, glycolipoprotein or free oligosaccharide comprising Fucα1→2Galβ1→3GalNAc.

7. The method according to claim 6 wherein the rat α1→2 fucosyltransferase is contacted with an oligosaccharide comprising a terminal Galβ1→3GalNAc moiety.

8. A method for the preparative synthesis of a molecule comprising Fuc α1→2 Galβ1→3 GalNAc, said method comprising contacting, a recombinant α1→2 fucosyltransferase comprising an amino acid sequence as depicted in FIG. 3A (SEQ ID NO: 10) with GDP-fucose and a molecule having a terminal Galβ1→3 GalNAc moiety and recovering the molecule comprising Fuc α1→2 Galβ1→3 GalNAc.

9. A method for the preparative synthesis of a molecule comprising Fuc α1→2 Galβ1→3 GalNAc, said method comprising contacting, a recombinant α1→2 fucosyltransferase consisting of an amino acid sequence as depicted in FIG. 5 (SEQ ID NO: 8) with GDP-fucose and a molecule having a terminal Galβ1→3 GalNAc moiety and recovering the molecule comprising Fuc α1→2 Galβ1→3 GalNAc.

10. A method for the preparative synthesis of a molecule comprising Fuc α1→2 Galβ1→3 GalNAc, said method comprising contacting, a recombinant α1→2 fucosyltransferase consisting of an amino acid sequence as depicted in FIG. 3A (SEQ ID NO: 10) with GDP-fucose and a molecule having a terminal Galβ1→3 GalNAc moiety and recovering the molecule comprising Fuc α1→2 Galβ1→3 GalNAc.

11. A method for the preparative synthesis of a molecule comprising Fuc α1→2 Galβ1→3 GalNAc, said method comprising contacting, a recombinant α1→2 fucosyltransferase the amino acid sequence of which consists of a catalytic domain defined by amino acids numbers 28-380 as depicted in FIG. 5 (SEQ ID NO: 8) or by amino acids numbered 1-353 as depicted in FIG. 3A (SEQ ID NO: 10).

12. The method according to claim 8 , wherein the molecule is a glycolipid, a glycoprotein, a glycolipoprotein or a free oligosaccharide.

13. The method according to claim 9 , wherein the molecule is a glycolipid, a glycoprotein, a glycolipoprotein or a free oligosaccharide.

14. The method according to claim 10 , wherein the molecule is a glycolipid, a glycoprotein, a glycolipoprotein or a free oligosaccharide.

15. The method according to claim 11 , wherein the molecule is a glycolipid, a glycoprotein, a glycolipoprotein or a free oligosaccharide.

16. A method for the preparative synthesis of a fucosyl-GM1, comprising contacting, a recombinant α1→2 fucosyltransferase comprising an amino acid sequence as depicted in FIG. 3A (SEQ ID NO: 10) with GDP-fucose and the ganglioside GM1, and recovering fucosyl-GM1.

17. A method for the preparative synthesis of a molecule comprising Fuc α1→2 Galβ1→3 GalNAc, said method comprising contacting,

(a) a recombinant α1→2 fucosyltransferase comprising the amino acid sequence depicted in FIG. 3A (SEQ ID NO: 10), or

(b) a cellular fraction of a recombinant cell containing a vector having a nucleotide sequence that encodes and expresses the recombinant α1→2 fucosyltransferase of (a), said cellular fraction containing the recombinant α1→2 fucosyltransferase and having α1→2 fucosyltransferase activity,

with GDP-fucose and a molecule having a terminal Galβ1→3 GalNAc moiety and recovering a molecule comprising Fuc α1→2 Galβ1→3 GalNAc.

18. The method according to claim 17 , wherein the molecule is a glycolipid, a glycoprotein, a glycolipoprotein, or a free oligosaccharide.

19. The method according to claim 16 , wherein the amino acid sequence is encoded by the nucleotide sequence as depicted as SEQ ID NO: 9.

20. The method according to claim 17 , wherein the amino acid sequence is encoded by the nucleotide sequence as depicted as SEQ ID NO: 9.

Assignments (1)
SECURITY AGREEMENT Recorded Apr 18, 2012
From: NORTHWEST BIOTHERAPEUTICS, INC.
To: FOUR M PURCHASERS, LLC
Reel/Frame 028069/0752 →